- Home
- TOVX vs AMIX Comparison
TOVX vs AMIX Comparison
Compare TOVX & AMIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOVX
- AMIX
- Stock Information
- Founded
- TOVX 2001
- AMIX 2014
- Country
- TOVX United States
- AMIX United States
- Employees
- TOVX N/A
- AMIX N/A
- Industry
- TOVX Biotechnology: Pharmaceutical Preparations
- AMIX
- Sector
- TOVX Health Care
- AMIX
- Exchange
- TOVX Nasdaq
- AMIX NYSE
- Market Cap
- TOVX 3.6M
- AMIX 4.4M
- IPO Year
- TOVX 2006
- AMIX N/A
- Fundamental
- Price
- TOVX $0.64
- AMIX $1.70
- Analyst Decision
- TOVX Hold
- AMIX Strong Buy
- Analyst Count
- TOVX 1
- AMIX 1
- Target Price
- TOVX N/A
- AMIX $5.00
- AVG Volume (30 Days)
- TOVX 2.4M
- AMIX 152.4K
- Earning Date
- TOVX 05-20-2025
- AMIX 05-30-2025
- Dividend Yield
- TOVX N/A
- AMIX N/A
- EPS Growth
- TOVX N/A
- AMIX N/A
- EPS
- TOVX N/A
- AMIX N/A
- Revenue
- TOVX N/A
- AMIX N/A
- Revenue This Year
- TOVX N/A
- AMIX N/A
- Revenue Next Year
- TOVX N/A
- AMIX N/A
- P/E Ratio
- TOVX N/A
- AMIX N/A
- Revenue Growth
- TOVX N/A
- AMIX N/A
- 52 Week Low
- TOVX $0.74
- AMIX $1.52
- 52 Week High
- TOVX $12.25
- AMIX $75.80
- Technical
- Relative Strength Index (RSI)
- TOVX 23.36
- AMIX 39.78
- Support Level
- TOVX $1.32
- AMIX $2.10
- Resistance Level
- TOVX $1.45
- AMIX $2.82
- Average True Range (ATR)
- TOVX 0.14
- AMIX 0.21
- MACD
- TOVX -0.07
- AMIX -0.02
- Stochastic Oscillator
- TOVX 2.92
- AMIX 1.75
About TOVX Theriva Biologics Inc.
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a lead clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.
About AMIX AUTONOMIX MEDICAL INC
Autonomix Medical Inc is a development-stage medical device development company focused on advancing innovative technologies for sensing and treating disorders relating to the nervous system. Its first-in-class technology platform includes a catheter-based microchip-enabled array that can detect and differentiate neural signals with a high degree of sensitivity as demonstrated in animal studies.